QILU PHARMACEUTICAL
Qilu Pharmaceutical is one of the leading pharmaceutical companies in China. Qilu focuses on the development, manufacturing and marketing of generic drugs and active pharmaceutical ingredients(APIs) in therapeutic areas including but not limited to Oncology, Cerebrovascular & Cardiovascular, Anti-infections, Psychological & Neurological Systems, Respiratory System, and Ophthalmological Diseases. Qilu has more than 15,000 employees, 70% of whom have a college degree or above. Qilu Pharmaceutical... consistently focuses on revolutionary development strategies guided by market demand and product innovation. Qilu has established extensive cooperation with domestic and international partners on multiple R&D projects. Devoted to the cultivation of talent, Qilu has invested in a highly qualified R&D team and efficient R&D capabilities. The 200+ new drug products successfully developed by Qilu constitutes as a large part of future production and sales for Qilu Pharmaceutical and partners. A number of technological achievements have garnered national and provincial scientific and technological progress awards for Qilu.
QILU PHARMACEUTICAL
Industry:
Pharmaceutical
Founded:
1958-01-01
Status:
Active
Contact:
+86-531-83127705
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Mobile Non Scaleable Content Amazon IPv6 Cloudflare Hosting Amazon Route 53
Current Employees Featured
Chuan-Chu Chou Chief Scientific Officer, Global Biologics R&D @ Qilu Pharmaceutical
Chief Scientific Officer, Global Biologics R&D
2018-05-01
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2018-07-01 | Regor Therapeutics | Qilu Pharmaceutical investment in Series A - Regor Therapeutics | N/A |
More informations about "Qilu Pharmaceutical"
Qilu Pharmaceutical - Crunchbase Investor Profile
Qilu has more than 15,000 employees, 70% of whom have a college degree or above. Qilu Pharmaceutical consistently focuses on revolutionary …See details»
Qilu Pharmaceutical Co., Ltd. - Drug pipelines, Patents, Clinical ...
Mar 6, 2025 Qilu Pharmaceutical is one of the leading pharmaceutical companies in China. Qilu focuses on the development, manufacturing and marketing of generic drugs and active …See details»
Qilu Pharma - Medtech Alert
Sep 26, 2022 Qilu Pharma is a leading vertically integrated pharmaceutical companies in China focused on discovering, developing, manufacturing and commercializing innovative medicines. With a diverse pipeline of noval …See details»
Biosimilars_Qilu pharmaceutical co.,ltd. | Caring …
Qilu pharmaceutical co.,ltd. | Caring through Science & Technology_Qilu pharmaceutical co.,ltd.-Located in Jinan, Qilu Pharmaceutical is one of the leading pharmaceutical companies in China. It focuses on developing.See details»
Company Profile-Shandong Anxin Pharmaceutical Co., Ltd.
Shandong Anxin Pharmaceutical Co., Ltd It is one of the subsidiaries of Qilu Pharmaceutical Group. It is a modern science and technology enterprise integrating API and preparation …See details»
Qilu Pharmaceutical - VentureRadar
"Focusing on the research and development of generic and innovative drugs, Qilu Pharmaceutical has formed a complete innovative development system covering early stage discovery, …See details»
News-Qilu pharmaceutical co.,ltd. | Caring through Science
Qilu Pharmaceutical ranks No.5 in the list of "Top 100 Enterprises in Chinese Pharmaceutical Industry” View details >>See details»
Company Profile of QILU PHARMACEUTICAL CO., LTD.
Qilu always commits itself to offering high-quality & trustworthy medicines to the world and improving people’s well-being. It is the first Chinese company to obtain both USFDA and …See details»
Organization | Qilu Pharmaceutical Co., Ltd.
QILU | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical (Hainan) Co., Ltd. | QILU PHARM CO LTD | QILU PHARM HAINAN | QILU TIANHE | Shandong Qilu Cell Therapy ...See details»
Qilu Pharmaceutical Company Profile | Management and
Qilu Pharmaceutical Profile and History Qilu Pharmaceutical is a leading vertically integrated pharmaceutical company focused on discovering, developing, manufacturing and …See details»
Qilu Pharmaceutical Group
Explore Qilu Pharmaceutical Group with its drug pipeline, therapeutic area, technology platform, 537 clinical trials, 68 news, and 112 literature, Disease Domain:Neoplasms, Immune System …See details»
QILU PHARMACEUTICAL GROUP - PharmaSource
Qilu Pharmaceutical Group is a prominent vertically integrated pharmaceutical company based in China, primarily engaged in the development, manufacture, and distribution of both finished …See details»
Qilu Pharmaceutical Co. Ltd. - BioCentury Company Profiles - BCIQ
Apr 21, 2023 Qilu Pharmaceutical Co. Ltd. - BioCentury Company Profiles for the biopharma industrySee details»
Qilu Pharmaceutical - PharmaSource
Qilu Pharmaceutical is a Manufacturer/Innovator company operating in the pharmaceutical industry. Qilu Pharmaceutical is one of the leading vertically integrated pharmaceutical …See details»
Qilu Pharmaceutical Company Profile - Office Locations ... - Craft
Qilu Pharmaceutical (齐鲁制药) is a company that develops, manufactures, and markets generic drugs and active pharmaceutical ingredients (APIs). Its product portfolio focuses on a range of …See details»
Qilu Pharmaceutical - Contacts, Employees, Board Members
Qilu Pharmaceutical has 1 current employee profile, Chief Scientific Officer, Global Biologics R&D Chuan-Chu Chou.See details»
Qilu Pharma Company Profile - Office Locations, Competitors
Qilu Pharma is a pharmaceutical company. It specializes in research and development, manufacturing, and marketing of generics and biosimilars medicines, as well as active …See details»
Qilu Pharmaceutical Gains Temporary FDA Approval to Import …
Jun 5, 2023 Timing and Distribution Details The permission was received by Qilu several weeks prior, with the company sending a letter to healthcare professionals on May 24 to notify them …See details»
Qilu Pharmaceutical Acquired an Exclusive Right for the …
Jul 31, 2021 Qilu Pharmaceutical announced an exclusive license agreement with Sesen Bio for the development and commercialization of Vicineum™ in Greater China on July 31st, 2020. …See details»
The unprecedented Paxlovid journey from milligrams to millions of ...
Mar 20, 2025 Yu et al. describe the challenges faced in the rapid development and upscaling of Paxlovid to meet the global demand for COVID-19 treatment. They respond to challenges by …See details»